Researchers at the University of Oxford achieved a first by successfully loading the complete genome of the hepatitis D virus onto a quantum computer, a significant step toward using the technology for biological discovery. The achievement was made possible through Wellcome Leap’s Quantum for Bio program, utilizing 117 qubits to encode the viral genome, pushing the boundaries of how much genetic information can be processed with this emerging technology. A major challenge for the field is demonstrating that quantum hardware can produce meaningful results for real-world scientific problems despite current limitations. By focusing on a clinically relevant virus, hepatitis D causes a severe and potentially fatal liver infection, the collaboration between the Universities of Oxford, Cambridge and Melbourne, the Wellcome Sanger Institute and Kyiv Academic University signals a move toward practical applications of quantum computing in public health.
Quantum Computing Advances in Genomics Research
The ability to encode an entire genome onto a quantum computer has been achieved for the first time, marking a substantial advance in applying this technology to biological research. The selection of the hepatitis D genome was deliberate, chosen for its relatively compact size of approximately 1,700 RNA bases while still representing a complete, clinically relevant genome responsible for a potentially fatal liver infection. This approach allowed the team to focus on developing methods to compress genomic data into quantum states, a critical step given the limitations of existing quantum hardware. Encoding the genome wasn’t a simple transfer of data; it required converting the sequence into a structure suitable for quantum representation and designing a precise operational sequence for a real quantum processor. This work was enabled by Wellcome Leap’s Quantum for Bio program, an international challenge designed to test whether useful biological and healthcare algorithms can be realized on current and emerging quantum hardware.
The successful encoding opens possibilities for tackling complex challenges in human health, including metagenomics and antimicrobial resistance, with the long-term goal of accelerating understanding of conditions like chromothripsis, a cancer mechanism that has proven resistant to classical computational analysis. Researchers believe more rapid and powerful genomic analysis could facilitate rapid tracking of infectious disease and allow precise identification of disease-causing genetic mutations.
Wellcome Leap’s Q4Bio Program & Pangenome Analysis
The Q4Bio program, a 30-month international challenge, aimed to determine if current quantum hardware could deliver useful results for biological and healthcare algorithms. The team specifically chose the hepatitis D genome, comprising around 1,700 bases of RNA, as a clinically relevant yet manageable starting point for developing methods to compress genomic information. Encoding the genome required 117 qubits on IBM’s 156-qubit Heron processor, necessitating the creation of novel approaches to represent genomic data within the limitations of existing quantum technology. Unlike classical computing, which relies on binary bits, quantum computers utilize qubits that can exist in multiple states simultaneously, offering the potential for exponentially larger computational spaces. However, researchers acknowledge that current quantum systems are highly sensitive and error-prone, making reliable computation difficult. This successful encoding isn’t simply about data storage; the challenge lay in preserving biologically relevant structure for future quantum algorithms.
However, current quantum systems remain highly sensitive and error-prone. Qubits are easily disrupted by noise and interference, making reliable large-scale computation extremely difficult.
